rs1553769261

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 5P and 2B. PM1PM2PP2BP4_Moderate

The NM_000388.4(CASR):​c.2951A>G​(p.Lys984Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

CASR
NM_000388.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.35
Variant links:
Genes affected
CASR (HGNC:1514): (calcium sensing receptor) The protein encoded by this gene is a plasma membrane G protein-coupled receptor that senses small changes in circulating calcium concentration. The encoded protein couples this information to intracellular signaling pathways that modify parathyroid hormone secretion or renal cation handling, and thus this protein plays an essential role in maintaining mineral ion homeostasis. Mutations in this gene are a cause of familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM1
In a topological_domain Cytoplasmic (size 215) in uniprot entity CASR_HUMAN there are 14 pathogenic changes around while only 2 benign (88%) in NM_000388.4
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CASR. . Gene score misZ 3.1237 (greater than the threshold 3.09). Trascript score misZ 4.8257 (greater than threshold 3.09). GenCC has associacion of gene with epilepsy, autosomal dominant hypocalcemia, familial hypocalciuric hypercalcemia 1, epilepsy, idiopathic generalized, susceptibility to, 8, neonatal severe primary hyperparathyroidism, autosomal dominant hypocalcemia 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.12238482).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CASRNM_000388.4 linkuse as main transcriptc.2951A>G p.Lys984Arg missense_variant 7/7 ENST00000639785.2 NP_000379.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CASRENST00000639785.2 linkuse as main transcriptc.2951A>G p.Lys984Arg missense_variant 7/71 NM_000388.4 ENSP00000491584 P1P41180-1
CASRENST00000498619.4 linkuse as main transcriptc.2981A>G p.Lys994Arg missense_variant 7/71 ENSP00000420194 P41180-2
CASRENST00000638421.1 linkuse as main transcriptc.2951A>G p.Lys984Arg missense_variant 7/75 ENSP00000492190 P1P41180-1
CASRENST00000490131.7 linkuse as main transcriptc.2720A>G p.Lys907Arg missense_variant 5/55 ENSP00000418685

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
70
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Autosomal dominant hypocalcemia 1;C1809471:Familial hypocalciuric hypercalcemia Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJun 15, 2017In summary, this variant has uncertain impact on CASR function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with a CASR-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces lysine with arginine at codon 984 of the CASR protein (p.Lys984Arg). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and arginine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.052
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
20
DANN
Benign
0.96
DEOGEN2
Benign
0.27
T;T;.;.
Eigen
Benign
-0.22
Eigen_PC
Benign
0.038
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.85
.;D;D;D
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.12
T;T;T;T
MetaSVM
Benign
-0.45
T
MutationAssessor
Benign
0.79
N;N;.;.
MutationTaster
Benign
0.95
D;D;D
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.20
.;.;N;.
REVEL
Benign
0.27
Sift
Benign
0.31
.;.;T;.
Sift4G
Benign
0.69
.;.;T;.
Polyphen
0.0050
B;B;.;.
Vest4
0.092
MutPred
0.14
.;.;Loss of ubiquitination at K994 (P = 0.0011);.;
MVP
0.85
MPC
0.51
ClinPred
0.55
D
GERP RS
5.8
Varity_R
0.11
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1553769261; hg19: chr3-122003752; API